Immediate Impact
32 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Standout
Works of Miho Kaneto being referenced
Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Miho Kaneto | 153 | 166 | 30 | 45 | 5 | 207 | |
| Lee C. Claridge | 165 | 97 | 39 | 17 | 8 | 277 | |
| Erin Wolf | 166 | 173 | 10 | 16 | 6 | 259 | |
| Koichiro Kusumoto | 230 | 132 | 39 | 14 | 6 | 267 | |
| Katherine Eberly | 240 | 128 | 50 | 27 | 9 | 283 | |
| Sui‐Weng Wong | 125 | 65 | 22 | 14 | 6 | 161 | |
| Carl G. Torres | 85 | 107 | 48 | 7 | 7 | 283 | |
| M M Stanley | 111 | 128 | 162 | 24 | 5 | 266 | |
| Stephen M. Wiener | 31 | 78 | 92 | 23 | 7 | 193 | |
| Rita M. Abdelmessih | 160 | 233 | 127 | 14 | 6 | 298 | |
| Wanqing Liu | 210 | 54 | 31 | 34 | 5 | 290 |
All Works
Loading papers...